RSS
kidney cancer
Adjuvant treatment for patients with renal cell carcinoma approved by FDA
The US Food and Drug Administration (FDA) has approved Sutent (sunitinib malate) for the adjuvant treatment for adult patients at a high risk of kidney cancer returning after nephrectomy. more
